Linked Data API

Show Search Form

Search Results

1134021
star this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans the Accelerated Access Collaborative has to prioritise products which help control hospital-acquired infections. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon remove filter
star this property uin 268509 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
star this property answer text <p>The Accelerated Access Collaborative (AAC) is interested in identifying and supporting strategically important products that will have the biggest impact on patient health outcomes and/or the delivery of NHS services. This may include those which help control hospital-acquired infections.</p><p>The AAC has already had made significant progress towards getting the best innovations to patients quicker and at a better cost for the National Health Service.</p><p>Since 2018, NHS England has been supporting SecurAcath and Plus Sutures, products designed to reduce infection rates, on the Innovation and Technology Payment programme. SecurAcath is a device to secure catheters that reduces the infection risk for patients with a peripherally inserted central catheter and has benefited over 80,000 patients. Seven trusts with higher than 4% surgical site infection rates have adopted Plus Sutures, a triclosan coated suture, with more trusts to be supported this year.</p><p> </p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-07-02T16:12:48.417Zmore like thisremove minimum value filter
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1137416
star this property registered interest false more like this
star this property date less than 2019-07-08more like thismore than 2019-07-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will list (a) the criteria and (b) the timelines for products to be considered in (i) the current and (ii) future review rounds of the Accelerated Access Collaborative. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon remove filter
star this property uin 274540 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-15more like thismore than 2019-07-15
star this property answer text <p>In October 2018, the Accelerated Access Collaborative (AAC) announced it was supporting the uptake of 12 high performing products, with the potential to improve the lives of up to 500,000 patients per year and save the National Health Service £30 million per year in England. All the products currently being supported by the AAC have been recommended by the National Institute for Health and Care Excellence, and therefore evidence on clinical benefits and cost savings were considered as part of the process.</p><p>The AAC board met on 26 June and had a positive discussion about future products and expects to announce further products later this year.</p><p>The AAC will consider the following areas of interest when determining which products to support:</p><p>- evidence of clinical and cost effectiveness;</p><p>- addressing significant unmet need;</p><p>- application to large populations or high budget impact; and</p><p>- enabling a novel mode of action or enabling significant changes to the care pathway.</p><p> </p><p> </p><p> </p>
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-07-15T15:23:36.753Zmore like thismore than 2019-07-15T15:23:36.753Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1137418
star this property registered interest false more like this
star this property date less than 2019-07-08more like thismore than 2019-07-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what criteria the Accelerated Access Collaborative uses in relation to decision-making on (a) medicines, (b) diagnostic tools and (c) digital services. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon remove filter
star this property uin 274542 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-15more like thismore than 2019-07-15
star this property answer text <p>The Accelerated Access Collaborative (AAC) is interested in supporting the most strategically important products that will have the biggest impact on patient health outcomes and delivery of National Health Service services.</p><p>When selecting products, the AAC will consider the following irrespective of innovation type (i.e. medicines, diagnostic tools, and digital products):</p><p>- evidence of clinical and cost effectiveness;</p><p>- addressing significant unmet need;</p><p>- application to large populations or high budget impact; and</p><p>- enabling a novel mode of action or enabling significant changes to the care pathway.</p><p>Further information is available at the following link:</p><p><a href="https://www.nice.org.uk/aac" target="_blank">https://www.nice.org.uk/aac</a></p><p> </p><p> </p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-07-15T15:33:03.587Zmore like thismore than 2019-07-15T15:33:03.587Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1144596
star this property registered interest false more like this
star this property date less than 2019-09-04more like thismore than 2019-09-04
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Alzheimer's Disease: Diagnosis more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to improve the early detection of Alzheimer's disease. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon remove filter
star this property uin 286747 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-09-09more like thismore than 2019-09-09
star this property answer text <p>Alzheimer's disease is the most common type of dementia in the United Kingdom.</p><p>The Challenge on Dementia 2020 sets out the ambition for two thirds of people with dementia to receive a formal diagnosis. This has been achieved and exceeded nationally. Our focus now is on reducing the variation in local diagnosis rates and NHS England have published guidance and put programmes in place to further improve the quality and timeliness of diagnosis across the country.</p><p>For example, the ‘Implementation guide and resource pack for dementia care’ published in July 2017 sets out key recommendations on how services should be configured to provide good quality diagnosis and post-diagnostic care for people with dementia and their carers. It includes key roles and activity in primary care and memory assessment services to facilitate an accurate and timely diagnosis of dementia, while ensuring access to appropriate support following diagnosis. The resource pack is available at the following link:</p><p><a href="https://www.england.nhs.uk/mental-health/dementia/implementation-guide-and-resource-pack-for-dementia-care/" target="_blank">https://www.england.nhs.uk/mental-health/dementia/implementation-guide-and-resource-pack-for-dementia-care/</a></p><p> </p><p> </p>
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-09-09T16:15:34.903Zmore like thismore than 2019-09-09T16:15:34.903Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1147887
star this property registered interest false more like this
star this property date less than 2019-10-02more like thismore than 2019-10-02
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cochlear Implants more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when the new cochlear implant for deafness be available on the NHS. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon remove filter
star this property uin 293581 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-10-08more like thismore than 2019-10-08
star this property answer text <p>NHS England commissions cochlear implants for patients who fulfil the criteria as described in the recently published he National Institute for Health and Care Excellence report ‘Cochlear implants for children and adults with severe to profound deafness: Technology appraisal guidance’ published on 7 March 2019 at the following link:</p><p><a href="https://www.nice.org.uk/guidance/ta566" target="_blank">https://www.nice.org.uk/guidance/ta566</a></p><p>There are a number of cochlear implant devices currently available. Specific advice about which of the devices currently available meet an individual patients requirements would be provided by a patient’s local specialist cochlear implant centre.</p><p> </p><p> </p><p> </p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-10-08T10:55:43.46Zmore like thismore than 2019-10-08T10:55:43.46Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1147899
star this property registered interest false more like this
star this property date less than 2019-10-02more like thismore than 2019-10-02
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Heart Diseases: Children more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of children in the UK diagnosed with congenital heart disease in each of the last five years. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon remove filter
star this property uin 293587 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-10-08more like thismore than 2019-10-08
star this property answer text <p>The following table shows the number of reported cases of spina bifida in England in the last three years for which data are available. These data include all reported cases of spina bifida registerable in accordance with European network of population-based registries for the epidemiological surveillance of congenital anomalies (EUROCAT) guidance which is available at the following link:</p><p><a href="https://eu-rd-platform.jrc.ec.europa.eu/eurocat" target="_blank">https://eu-rd-platform.jrc.ec.europa.eu/eurocat</a></p><p>These data exclude spontaneous miscarriage before 20 weeks gestation and cases of spina bifida occulta.</p><p> </p><p>Number of reported cases of spina bifida in England, 2015 - 2017</p><table><tbody><tr><td><p>Year of birth</p></td><td><p>Number of reported spina bifida cases</p></td><td><p>Total number of births (coverage)</p></td><td><p>Total number of births in England</p></td><td><p>Estimated number of cases for England</p></td></tr><tr><td><p>2015</p></td><td><p>75</p></td><td><p>141,474</p></td><td><p>667,351</p></td><td><p>354</p></td></tr><tr><td><p>2016</p></td><td><p>204</p></td><td><p>329,301</p></td><td><p>666,050</p></td><td><p>413</p></td></tr><tr><td><p>2017</p></td><td><p>181</p></td><td><p>320,013</p></td><td><p>649,330</p></td><td><p>367</p></td></tr></tbody></table><p>Source: <a href="https://www.gov.uk/government/publications/ncardrs-congenital-anomaly-annual-data" target="_blank">https://www.gov.uk/government/publications/ncardrs-congenital-anomaly-annual-data</a></p><p> </p><p>The following table shows the estimated number of cases of congenital heart disease in England in the last three years for which data are available. These data include all reported cases of CHD registerable in accordance with European network of population-based registries for the epidemiological surveillance of congenital anomalies (EUROCAT) guidance which can be viewed at the following link</p><p><a href="https://eu-rd-platform.jrc.ec.europa.eu/eurocat" target="_blank">https://eu-rd-platform.jrc.ec.europa.eu/eurocat</a></p><p>This is likely to be an under-estimate of the actual number of cases as milder forms of congenital heart disease are often diagnosed later.</p><p> </p><p>The estimated number of reported cases of congenital heart disease in England, 2015 - 2017</p><table><tbody><tr><td><p>Year of birth</p></td><td><p>Number of reported CHD cases</p></td><td><p>Total number of births (coverage)</p></td><td><p>England Total number of births in England</p></td><td><p>Estimated number of cases for England</p></td></tr><tr><td><p>2015</p></td><td><p>706</p></td><td><p>141,474</p></td><td><p>667,351</p></td><td><p>3,330</p></td></tr><tr><td><p>2016</p></td><td><p>2,169</p></td><td><p>329,301</p></td><td><p>666,050</p></td><td><p>4,387</p></td></tr><tr><td><p>2017</p></td><td><p>2,188</p></td><td><p>320,013</p></td><td><p>649,330</p></td><td><p>4,440</p></td></tr></tbody></table><p> </p><p>Source: <a href="https://www.gov.uk/government/publications/ncardrs-congenital-anomaly-annual-data" target="_blank">https://www.gov.uk/government/publications/ncardrs-congenital-anomaly-annual-data</a></p><p> </p><p> </p><p> </p><p> </p>
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
unstar this property grouped question UIN 293583 more like this
star this property question first answered
less than 2019-10-08T10:58:35.757Zmore like thismore than 2019-10-08T10:58:35.757Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1137417
star this property registered interest false more like this
star this property date less than 2019-07-08more like thismore than 2019-07-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Hospitals: Infectious Diseases more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans the Accelerated Access Collaborative has to prioritise products which help to control hospital-acquired infections. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon remove filter
star this property uin 274541 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-15more like thismore than 2019-07-15
star this property answer text <p>The Accelerated Access Collaborative (AAC) is interested in identifying and supporting strategically important products that will have the biggest impact on patient health outcomes and/or the delivery of National Health Service services. This may include those which help control hospital-acquired infections.</p><p>The AAC has already had made significant progress towards getting the best innovations to patients quicker and at a better cost for the NHS.</p><p>Since 2018, NHS England has been supporting SecurAcath and Plus Sutures, products designed to reduce infection rates, on the Innovation and Technology Payment programme. SecurAcath is a device to secure catheters that reduces the infection risk for patients with a peripherally inserted central catheter and has benefited over 80,000 patients. Seven trusts with higher than 4% surgical site infection rates have adopted Plus Sutures, a triclosan coated suture, with more trusts to be supported this year.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p>
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-07-15T15:26:22.27Zmore like thismore than 2019-07-15T15:26:22.27Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1147895
star this property registered interest false more like this
star this property date less than 2019-10-02more like thismore than 2019-10-02
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Idiopathic Pulmonary Fibrosis more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how many people have been diagnosed with pulmonary fibrosis by (a) age and (b) gender in each of the last three years. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon remove filter
star this property uin 293585 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-10-08more like thismore than 2019-10-08
star this property answer text <p>The information requested on pulmonary fibrosis diagnoses is provided in the attached document.</p><p> </p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-10-08T11:07:40.693Zmore like thismore than 2019-10-08T11:07:40.693Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property attachment
1
unstar this property file name PQ293585 response.xlsx more like this
star this property title pq293585 table more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1139402
star this property registered interest false more like this
star this property date less than 2019-07-16more like thismore than 2019-07-16
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Medicine: Research more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what discussions he has had with the Chancellor of the Exchequer on the adequacy of funding for medical R&D in advance of the Spending Review. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon remove filter
star this property uin 277741 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-25more like thismore than 2019-07-25
star this property answer text <p>My Rt. hon. Friend the Secretary of State for Health and Social Care met regularly with the former Chancellor (Rt. hon Philip Hammond MP) and other Cabinet colleagues to discuss a range of issues related to funding for medical research and development.</p><p>The Department’s National Institute for Health Research (NIHR) budget for 2019/20 is just over £1 billion and welcomes funding applications for research into any aspect of human health. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. Information on individual projects funded by the NIHR can be found at the following link:</p><p><a href="https://www.journalslibrary.nihr.ac.uk/programmes/" target="_blank">https://www.journalslibrary.nihr.ac.uk/programmes/</a></p><p>The future of budgets outside of the NHS England resource settlement, including capital budgets for research and development, will be confirmed later this year at the Spending Review 2019.</p><p> </p>
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-07-25T14:20:17.517Zmore like thismore than 2019-07-25T14:20:17.517Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1140794
star this property registered interest false more like this
star this property date less than 2019-07-22more like thismore than 2019-07-22
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Medicine: Research more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent assessment he has made of UK capacity in translational research. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon remove filter
star this property uin 280239 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-26more like thismore than 2019-07-26
star this property answer text <p>The Medical Research Council (MRC) covers basic through to translational research, with translational research and applied, clinical, public health and social care research funded by the Department via the National Institute for Health Research (NIHR).</p><p>The NIHR’s funding for research includes support for research infrastructure which is critically important in providing the resources, support and facilities that the National Health Service needs to conduct first-class research across the full pathway of discovery science to evaluation. The sustained, long-term funding to put in place through the NIHR infrastructure has been widely recognised as having transformed the health research environment in the United Kingdom. For example, there has been five-fold increase in early phase (phase I and phase II) trials since 2009 within the NIHR early translational research infrastructure in the NHS (2,842 phase I and phase II trials in 2017/18 compared to just 496 in 2009/10).</p><p>The MRC are also currently undertaking an evaluation of 10 years of MRC-funded translation research which is expected to be completed in September 2019.</p><p>The MRC and the NIHR also work in partnership through the Efficacy and Mechanism Evaluation programme which funds studies evaluating interventions with potential to make a step-change in the promotion of health, treatment of disease and improvement of rehabilitation or long-term care.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p>
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-07-26T11:44:44.86Zmore like thismore than 2019-07-26T11:44:44.86Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this